2531 - 2540 of 7785 Results
Title
Year
- Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist2021RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Citation Count: 14
- Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson disease2021RESTRICTEDTitle: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson diseaseJournal Name: Interdisciplinary NeurosurgeryPublisher: Elsevier BVVol: 25Issue #:Start Page: 101224End Page: 101224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.inat.2021.101224Best OA location URL: https://doi.org/10.1016/j.inat.2021.101224Citation Count: 1
-
RESTRICTEDTitle: Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 27End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.024Best OA location URL: http://manuscript.elsevier.com/S135380202100273X/pdf/S135380202100273X.pdfCitation Count: 8
- Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study2021RESTRICTEDTitle: Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation studyJournal Name: Neuroimage: ReportsPublisher: Elsevier BVVol: 1Issue #: 3Start Page: 100026End Page: 100026Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ynirp.2021.100026Best OA location URL: https://doi.org/10.1016/j.ynirp.2021.100026Citation Count: 13
- Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study2021RESTRICTEDTitle: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 739End Page: 752Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00214-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711249Citation Count: 258
- Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation2021RESTRICTEDTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 7
- Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders2021RESTRICTEDTitle: Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative DisordersJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 35Issue #: 7Start Page: 531End Page: 550Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2021.0081Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388249Citation Count: 22
- Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”2021RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0
- Reply to: “α‐Synuclein ( SNCA ) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”2021RESTRICTEDTitle: Reply to: “α‐Synuclein ( SNCA ) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2212End Page: 2213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28742Citation Count: 0
-
RESTRICTEDTitle: Seeking progress in disease modification in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 90Issue #:Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.006Citation Count: 10